Trump’s Medicaid Drug Pricing Move to Save Billions
President Donald Trump recently announced a significant policy change that aims to implement “most favored nation” pricing for prescription drugs under Medicaid, covering all 50 states, the District of Columbia, and Puerto Rico. This initiative could potentially save state governments around $27.6 billion.
In a press release issued on Friday, the White House highlighted that there has been the most substantial annual reduction in prescription drug prices in over six decades. They mentioned that Trump is the first president to achieve a drop in drug prices, referencing data from the Bureau of Labor Statistics (BLS) Consumer Price Index (CPI) over the first 19 months of each presidency since Richard Nixon.
“Official data confirms the largest annual decline in more than 60 years — the steepest drop since 1963 — with prices falling every month of 2026,” noted the White House.
Under this Most Favored Nation pricing model, which Trump initially introduced through an executive order in May, 26 major pharmaceutical companies—representing 90% of the branded prescription drug market in the U.S.—have agreed to set U.S. prices in line with those in similar developed nations.
The administration forecasts that these agreements will help Americans save over $600 billion, citing a 2024 Rand Health Quarterly (RHQ) analysis indicating that prescription medications are almost three times more expensive for Americans compared to prices in other countries.
Furthermore, the initiative will unlock nearly $65 billion in Medicaid drug savings over the next ten years for all the states, along with D.C. and Puerto Rico. This move is expected to provide real financial relief to low-income families, children, seniors, and individuals with disabilities, and it’s considered a substantial win for taxpayers.
“Every state will now have the ability to use those extra billions of dollars to invest in other healthcare improvements or something else,” Trump remarked in the Oval Office on Friday. He also added, “I will not get any credit for it, but when prescription drugs come down… everything becomes a lot less expensive. So, perhaps you can think of me as you watch the prices come down to the floor.”
Prices under the Most Favored Nation framework were first introduced on TrumpRx, a platform that resembles GoodRx, where uninsured individuals can access coupons for discounts of up to 98% on over 80 medications, including fertility drugs, inhalers, insulin, cholesterol treatments, and weight loss medications.
On the same day, the White House revealed that the 26 pharmaceutical companies involved have committed to investing approximately $170 billion into U.S. manufacturing, as well as research and development, which should reduce the country’s dependence on foreign supply chains for medicines.
